Albemarle Corp. delivered an 80% total return in 2025, outpacing most diversified chemical peers as lithium prices surged. The company’s global lithium extraction assets in Chile and Australia benefited from robust Chinese electric-vehicle production, while its recently expanded processing facility in North Carolina ramped to 90% capacity utilization by year-end. This strong performance underscores Albemarle’s leading position in the lithium market and the growing role of battery-grade products in its revenue mix.

Albemarle will report its fourth-quarter 2025 results after market close on February 11, 2026, with a conference call scheduled for 8 a.m. EST on February 12. Management indicated on the call that analysts consensus for full-year sales of $8.6 billion and adjusted EBITDA of $3.1 billion will be key benchmarks. Investors will scrutinize guidance for 2026, especially planned capital expenditures of $700 million focused on expanding lithium hydroxide capacity by 20% and downstream bromine applications.

On January 13, Albemarle was named to Zacks’ Rank #1 Momentum Stocks list, joining only two other companies. The designation reflects a 25% price advance in the first two weeks of January, driven by a 30% year-to-date rise in lithium carbonate benchmark prices and renewed optimism around energy-storage projects. Analysts highlight Albemarle’s tight cost structure, with 2025 unit cash costs falling by 12%, as a catalyst for continued earnings leverage.

Albemarle shares recently hit a new 52-week high, propelled by expectations that battery metals demand will outstrip supply throughout 2026. The company’s announcement of a strategic supply agreement with a leading North American automaker for 100,000 metric tons of lithium hydroxide over five years bolstered sentiment. Market participants point to improving margins in the by-product bromine segment and a 15% year-over-year increase in global EV registrations as supporting factors for sustained share price strength.